Ischemic modified albumin as a new biomarker in predicting of oxidative stress in alopecia areata | Zendy

Hatice Ataş | Zendy; Müzeyyen Gönül | Zendy; Yasin Öztürk | Zendy; Mustafa Kavutçu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ischemic modified albumin as a new biomarker in predicting of oxidative stress in alopecia areata

Author(s) -

Hatice Ataş,

Müzeyyen Gönül,

Yasin Öztürk,

Mustafa Kavutçu

Publication year - 2019

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-1708-35

Subject(s) - medicine , oxidative stress , alopecia areata , biomarker , albumin , ischemia modified albumin , disease , confounding , antioxidant , pathogenesis , clinical significance , gastroenterology , endocrinology , immunology , ischemia , biochemistry , biology , myocardial ischemia

Results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers used can be confounding. Thus, we aimed to investigate the role of oxidative stress in the pathogenesis of AA through an evaluation of ischemia-modified albumin (IMA); other markers of the oxidant/antioxidant system, such as SOD, CAT, GSH-ST, and MDA; and contributing clinical risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research